Janssen Reports First Results of TAR-200 and Cetrelimab Study in Non-Muscle-Invasive Bladder Cancer

Study results of novel drug-eluting technology highlight potential durability of TAR-200 in patient population with high unmet need T...

May 01, 2023 | Monday | News
Corning's New Advanced Flow Pharmaceutical Technology Services Will Help Speed the Creation of Future Medicines

Corning Incorporated  announced the launch of its Advanced Flow Pharmaceutical Technology (AFPT) services business to help contract development m...

April 27, 2023 | Thursday | News
Government of Ontario Invests in Virica Biotech

The expansion project aims to (i) grow Virica’s bioprocessing capacity to keep pace with client demand for scaling up viral medicines, (ii) advance n...

April 24, 2023 | Monday | News
Sanofi Launches AVAXIM® Junior in UK for Hepatitis A Virus Immunisation in Children

Sanofi (EURONEXT: SAN and NASDAQ: SNY) has today announced the launch of AVAXIM® Junior in the UK, an inactive hepatitis A vaccine indicated for use in...

April 24, 2023 | Monday | News
FDA Authorizes Changes to Simplify Use of Bivalent mRNA COVID-19 Vaccines

What You Need to Know: Most individuals, depending on age, previously vaccinated with a monovalent COVID-19 vaccine who have not yet received a dose of ...

April 19, 2023 | Wednesday | Regulatory
Nona Biosciences & Washington University Partner to Combat RNA Viruses

"This collaboration represents an exciting opportunity for Nona Biosciences to leverage its fully human antibody H2L2 transgenic mice, together with the te...

April 19, 2023 | Wednesday | News
Evaxion and Pennsylvania State University publish preclinical data validating our AI-based viral vaccine discovery platform

The published data showcase how Evaxion's proprietary AI-platform, RAVEN (Rapidly Adaptive Viral Response), identifies broad and robust T-cell epitopes fro...

April 13, 2023 | Thursday | News
UM School of Medicine Researchers Chart Path Forward on Developing mRNA Vaccines for Infections Beyond COVID-19

After helping to develop and test new mRNA technologies for COVID-19 vaccines, University of Maryland School of Medicine (UMSOM) researchers and scientists...

April 10, 2023 | Monday | News
In Pursuit of a Lyme Disease Vaccine: Why We Need It and What It Has the Potential to Do

Lyme disease is the most common vector-borne illness in the United States.2 And yet, the actual cases are vastly underreported. The U.S. Centers for Diseas...

April 09, 2023 | Sunday | Opinion
Tonix Pharmaceuticals Presents Data from its Vaccine Development Program at the World Vaccine Congress

Preclinical data demonstrate the efficacy of TNX‐801 vaccination against mpox virus challenge in a non-human primate model   Phase 1 trial with TN...

April 09, 2023 | Sunday | News
Seegene declares it will share syndromic PCR technologies to prevent future pandemics

- Localization of Seegene Syndromic PCR technologies with global partners for versatile and proactive response to local emerging healthcare demands.- Forma...

April 07, 2023 | Friday | News
PharmaJet's partner Gennova Biopharmaceuticals seeks EAU in India for needle-free Omicron Booster mRNA vaccine

Interim report of the safety and immunogenicity endpoints from the Phase II/III study has been submitted to the Drug Controller General of India (DCGI) f...

April 05, 2023 | Wednesday | News
Alzamend Neuro Begins Phase I/IIA Trial of Immunotherapy Vaccine for Alzheimer's

The purpose of this trial is to assess the safety, tolerability, and efficacy of multiple ascending doses of ALZN002 compared with that of placebo in 20-30...

April 04, 2023 | Tuesday | News
Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer’s Disease

Data shows reduction of microglia activation and improvement in behavior in rodent model of Alzheimer’s disease (AD) Modulation of neuroinflammati...

March 31, 2023 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close